Human Resources
Men are more likely to be manipulative colleagues than women

Human Resources: An Australian study of almost 800 people has found that men are more likely to engage in malicious emotional manipulation in the workplace than women.
This study investigated people’s willingness to emotionally manipulate others maliciously and disingenuously in the workplace. It also examined the role of gender, emotional intelligence, and the Dark Triad traits (machiavellianism (a manipulative attitude), narcissism (excessive self-love), and psychopathy (lack of empathy) in this destructive behaviour.
T‐tests revealed that females were significantly less likely than males to engage in both malicious and disingenuous emotional manipulation.
The study found that emotional manipulation is higher in men who have a relentless drive to achieve goals, and in women with broader deceptive tendencies. The study also suggests there is a ‘dark side to emotional intelligence’ at work, as those who were more in touch with their own emotions and those of others, also tended to be more manipulative.
In females, the magnitude of correlations (small to moderate) between the Dark Triad traits and both forms of emotional manipulation were similar. In males, both forms of emotional manipulation most strongly correlated with Machiavellianism, followed by narcissism, then psychopathy.
This study is the first to demonstrate that good emotional intelligence skills can facilitate undesirable workplace behaviours.
Digital & Innovation
Health sector faces new privacy obligations
Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]
MoreNews - Pharmaceuticals
TGA approves new antibiotic but AMR blind spot remains a critical concern
The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]
MoreNews - MedTech & Diagnostics
BCAL Diagnostics rejects merger speculation
ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]
MoreNews - Pharmaceuticals
Australia backs infectious disease innovation as US funding faces more cuts
Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]
More